Ligand validation:6EHD

C8E: (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE

C8E is a Ligand Of Interest in 6EHD designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6EHD_C8E_A_409	64%	60%	0.105	0.903	0.41	1.08	-	2	3	0	100%	1
6EHD_C8E_A_405	51%	64%	0.096	0.916	0.41	0.93	-	-	0	0	62%	0.619
6EHD_C8E_A_407	48%	73%	0.114	0.901	0.48	0.55	-	-	0	0	76%	0.7619
6EHD_C8E_A_404	46%	49%	0.132	0.865	0.64	1.34	-	5	2	0	100%	1
6EHD_C8E_A_401	28%	65%	0.14	0.86	0.55	0.78	-	-	0	0	62%	0.619
6EHD_C8E_A_410	23%	67%	0.141	0.837	0.35	0.89	-	-	3	0	57%	0.5714
6EHD_C8E_A_402	20%	70%	0.112	0.841	0.59	0.54	-	-	0	0	29%	0.2857
6EHD_C8E_A_403	16%	89%	0.175	0.844	0.46	0.19	-	-	0	0	43%	0.4286
6EHD_C8E_A_406	8%	17%	0.192	0.751	1.01	2.71	1	3	6	0	52%	0.5238
6EHD_C8E_A_408	3%	63%	0.172	0.572	0.66	0.74	-	-	0	0	62%	0.619
6EHE_C8E_A_401	29%	89%	0.143	0.931	0.43	0.22	-	-	0	0	29%	0.2857
5FOK_C8E_A_1725	80%	74%	0.099	0.949	0.47	0.53	-	-	2	0	100%	1
5MDO_C8E_B_404	61%	73%	0.118	0.908	0.36	0.65	-	-	0	0	100%	1
5DL7_C8E_A_506	61%	47%	0.123	0.912	0.72	1.34	-	3	4	0	100%	1
6HCP_C8E_C_824	59%	77%	0.116	0.924	0.46	0.46	-	-	1	0	86%	0.8571
3RGN_C8E_A_804	55%	71%	0.131	0.899	0.42	0.69	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.